NLT-101

N/A

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameNLT-101
Drug Alias NameNLT-101NLT101
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNula Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNula Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A